SAN FRANCISCO -- Despite growing concerns about the transmission of Severe Acute Respiratory Syndrome (SARS) in the U.S. workplace, a majority of businesses consider SARS a minor problem, according to a poll of 135 senior-level legal and human resources executives taken late last week. The survey also found that more than 70 percent of the companies questioned have yet to develop any type of response plan for SARS.
The survey was conducted Friday, April 11, 2003 among attendees at a national employment law conference hosted in Phoenix by Littler Mendelson, the nation's largest employment and labor law firm. "While those numbers are disturbing, they also are somewhat predictable," said Garry Mathiason, senior partner at Littler Mendelson. "There is a substantial underestimation of the potential impact of SARS in the United States primarily because the war coverage has blotted everything out. We don't see what's occurring in other countries, where the epidemic is much further along."
Attendees at the conference represented a wide range of U.S. employers, including a number of Fortune 500 firms. Twenty-three percent of respondents said SARS was not a threat to their business, 55 percent said it was a minor threat, while 22 percent said it was a serious threat. Seventy-two percent said their organization does not have a SARS response plan in place, while 21 percent said their company does have a plan. Seven percent did not know if a plan is in place.
"With what we now know about SARS, and its potential for severe workplace consequences, it is critical that companies understand the threat is real and establish response plans to protect their workers and their own interests," said Jeff Tanenbaum, senior partner and co-chair of Littler's occupational safety and health group. He suggests that the best approach for most employers is to develop and implement a communicable illness policy and response plan. "SARS is a major concern, but it is not the only communicable illness for which employers must be prepared, and the issues raised by any such illnesses are often quite similar," noted Tanenbaum, who has led the development of Littler's model communicable illness policy and compliance package.
Source: Littler Mendelson
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.